Qiagen NV (NASDAQ:QGEN)
| 18.68 Data as of May 22 |  +0.10 / +0.54%Today’s Change | 15.66 Today|||52-Week Range 22.20 | +2.92% Year-to-Date |
Latest QGEN News | Press Releases
| 5 Stocks Improving Performance Of The Diversified Services Industry May 22 / TheStreet.com | QIAGEN Downgraded to Strong Sell - Analyst Blog May 21 / Zacks.com |
Today’s Trading
| Previous close | 18.58 |
| Today’s open | 18.86 |
| Day’s range | 18.66 - 19.04 |
| Volume | 984,193 |
| Average volume (3 months) | 839,295 |
| Market cap | $4.4B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +34.15% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +9.50% |
| Revenue growth (last year) | +7.24% |
| P/E ratio | 43.4 |
| Price/Sales | 3.39 |
| Price/Book | 1.61 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PKIPerkinElmer Inc | -0.72 | -2.21% |
| BRKRBruker Corp | -0.42 | -2.42% |
| FEICFEI Co | -1.44 | -2.00% |
| BIOBio-Rad Laboratories... | -0.73 | -0.63% |
Data as of 4:03pm ET, 05/22/2013
Financials
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | $0.25 |
| Annual revenue (last year) | $1.3B |
| Annual profit (last year) | $129.5M |
| Net profit margin | 10.32% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman- Supervisory Board Detlev H. Riesner, PhD |
Chief Executive Officer & Managing Director Peer M. Schatz, MBA |
Corporate headquarters Venlo, Limburg |
Forecasts
